2022 Regular SessionFlorida Legislature

S0678: Prescription Insulin Drugs

Legislative Summary

Requiring individual and group health insurance policies, respectively, to cap an insured's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; providing that coverage for prescription insulin drugs may not be subject to a deductible; requiring health benefit plans that cover small employers to comply with prescription insulin drug cost-sharing requirements; requiring health maintenance contracts to cap a subscriber's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount, etc.

Demographic Impact

Overall analysis of equity impact

80% Positive
High ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

10/27/2021
Filed
Senate
11/16/2021
Referred to Banking and Insurance; Appropriations Subcommittee on Agriculture, Environment, and General Government; Appropriations
Senate
1/11/2022
Introduced
Senate
3/12/2022
Indefinitely postponed and withdrawn from consideration
Senate
3/14/2022
Died in Banking and Insurance
Senate

Status Information

Current Status
Failed(3/14/2022)
Chamber
Senate
Sine DiePrior Session

Sponsors

Democrat: 1

Primary Sponsor

Janet Cruz
Janet Cruz
Democrat

Documents

Introduced
Bill Text10/27/20218.2 KB